High-Dose Vitamin D Supplementation Improves Microcirculation and Reduces Inflammation in Diabetic Neuropathy Patients

Overview

Journal Nutrients

Date 2020 Aug 23

PMID 32825324

Citations 34

Authors

Tatiana Karonova

Anna Stepanova

Anna Bystrova

Edward B Jude

Affiliations

Soon will be listed here.

Abstract

We assessed the effect of different doses of vitamin D supplementation on microcirculation, signs and symptoms of peripheral neuropathy and inflammatory markers in patients with type 2 diabetes (T2DM). Sixty-seven patients with T2DM and peripheral neuropathy (34 females) were randomized into two treatment groups: Cholecalciferol 5000 IU and 40,000 IU once/week orally for 24 weeks. Severity of neuropathy (NSS, NDS scores, visual analogue scale), cutaneous microcirculation (MC) parameters and inflammatory markers (ILs, CRP, TNFα) were assessed before and after treatment. Vitamin D deficiency/insufficiency was detected in 78% of the 62 completed subjects. Following treatment with cholecalciferol 40,000 IU/week, a significant decrease in neuropathy severity (NSS, = 0.001; NDS, = 0.001; VAS, = 0.001) and improvement of cutaneous MC were observed ( < 0.05). Also, we found a decrease in IL-6 level (2.5 pg/mL vs. 0.6 pg/mL, < 0.001) and an increase in IL-10 level (2.5 pg/mL vs. 4.5 pg/mL, < 0.001) after 24 weeks of vitamin D supplementation in this group. No changes were detected in the cholecalciferol 5000 IU/week group. High-dose cholecalciferol supplementation of 40,000 IU/week for 24 weeks was associated with improvement in clinical manifestation, cutaneous microcirculation and inflammatory markers in patients with T2DM and peripheral neuropathy.

Citing Articles

The Role of Inflammation in the Pathogenesis of Diabetic Peripheral Neuropathy: New Lessons from Experimental Studies and Clinical Implications.

Panou T, Gouveri E, Popovic D, Papazoglou D, Papanas N Diabetes Ther. 2025; 16(3):371-411.

PMID: 39928224 PMC: 11868477. DOI: 10.1007/s13300-025-01699-7.

Does Systematic Use of Small Doses of Vitamin D Have Anti-Inflammatory Effects and Effectively Correct Deficiency Among Healthy Adults?.

Walawska-Hrycek A, Hrycek E, Galus W, Jedrzejowska-Szypulka H, Krzystanek E Nutrients. 2025; 17(2).

PMID: 39861482 PMC: 11769303. DOI: 10.3390/nu17020352.

Vitamin D: Evidence-Based Health Benefits and Recommendations for Population Guidelines.

Grant W, Wimalawansa S, Pludowski P, Cheng R Nutrients. 2025; 17(2).

PMID: 39861407 PMC: 11767646. DOI: 10.3390/nu17020277.

Effect of Vitamin D Supplementation on Inflammatory Markers in Obese Patients with Acute and Chronic Orthopedic Conditions.

Gawryjolek M, Wicinski M, Zabrzynska M, Ohla J, Zabrzynski J Nutrients. 2024; 16(21).

PMID: 39519568 PMC: 11547427. DOI: 10.3390/nu16213735.

Vitamin D Supplementation: Shedding Light on the Role of the Sunshine Vitamin in the Prevention and Management of Type 2 Diabetes and Its Complications.

Vasdeki D, Tsamos G, Dimakakos E, Patriarcheas V, Koufakis T, Kotsa K Nutrients. 2024; 16(21).

PMID: 39519484 PMC: 11547801. DOI: 10.3390/nu16213651.

References

Moreira-Lucas T, Duncan A, Rabasa-Lhoret R, Vieth R, Gibbs A, Badawi A . Effect of vitamin D supplementation on oral glucose tolerance in individuals with low vitamin D status and increased risk for developing type 2 diabetes (EVIDENCE): A double-blind, randomized, placebo-controlled clinical trial. Diabetes Obes Metab. 2016; 19(1):133-141. DOI: 10.1111/dom.12794. View

Alamdari A, Mozafari R, Tafakhori A, Faghihi-Kashani S, Hafezi-Nejad N, Sheikhbahaei S . An inverse association between serum vitamin D levels with the presence and severity of impaired nerve conduction velocity and large fiber peripheral neuropathy in diabetic subjects. Neurol Sci. 2015; 36(7):1121-6. DOI: 10.1007/s10072-015-2207-0. View

Hawker G, Mian S, Kendzerska T, French M . Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain.... Arthritis Care Res (Hoboken). 2012; 63 Suppl 11:S240-52. DOI: 10.1002/acr.20543. View

Gagnon C, Lu Z, Magliano D, Dunstan D, Shaw J, Zimmet P . Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle study). Diabetes Care. 2011; 34(5):1133-8. PMC: 3114481. DOI: 10.2337/dc10-2167. View

Colotta F, Jansson B, Bonelli F . Modulation of inflammatory and immune responses by vitamin D. J Autoimmun. 2017; 85:78-97. DOI: 10.1016/j.jaut.2017.07.007. View

Jamwal S, Sharma S . Vascular endothelium dysfunction: a conservative target in metabolic disorders. Inflamm Res. 2018; 67(5):391-405. DOI: 10.1007/s00011-018-1129-8. View

Munoz-Garach A, Garcia-Fontana B, Munoz-Torres M . Vitamin D Status, Calcium Intake and Risk of Developing Type 2 Diabetes: An Unresolved Issue. Nutrients. 2019; 11(3). PMC: 6471926. DOI: 10.3390/nu11030642. View

Straube S, Derry S, Straube C, Moore R . Vitamin D for the treatment of chronic painful conditions in adults. Cochrane Database Syst Rev. 2015; (5):CD007771. PMC: 6494161. DOI: 10.1002/14651858.CD007771.pub3. View

Chapman D, Foxcroft R, Dale-Harris L, Ronte H, Bidgoli F, Bellary S . Insights for Care: The Healthcare Utilisation and Cost Impact of Managing Type 2 Diabetes-Associated Microvascular Complications. Diabetes Ther. 2019; 10(2):575-585. PMC: 6437252. DOI: 10.1007/s13300-018-0548-4. View

10.

Jackson J, Judd S, Panwar B, Howard V, Wadley V, Jenny N . Associations of 25-hydroxyvitamin D with markers of inflammation, insulin resistance and obesity in black and white community-dwelling adults. J Clin Transl Endocrinol. 2016; 5:21-25. PMC: 5098550. DOI: 10.1016/j.jcte.2016.06.002. View

11.

Magrinelli F, Briani C, Romano M, Ruggero S, Toffanin E, Triolo G . The Association between Serum Cytokines and Damage to Large and Small Nerve Fibers in Diabetic Peripheral Neuropathy. J Diabetes Res. 2015; 2015:547834. PMC: 4415740. DOI: 10.1155/2015/547834. View

12.

Mazidi M, Toth P, Banach M . C-reactive Protein Is Associated With Prevalence of the Metabolic Syndrome, Hypertension, and Diabetes Mellitus in US Adults. Angiology. 2017; 69(5):438-442. DOI: 10.1177/0003319717729288. View

13.

Pittas A, Dawson-Hughes B, Sheehan P, Ware J, Knowler W, Aroda V . Vitamin D Supplementation and Prevention of Type 2 Diabetes. N Engl J Med. 2019; 381(6):520-530. PMC: 6993875. DOI: 10.1056/NEJMoa1900906. View

14.

Maddaloni E, Cavallari I, Napoli N, Conte C . Vitamin D and Diabetes Mellitus. Front Horm Res. 2018; 50:161-176. DOI: 10.1159/000486083. View

15.

Gil A, Plaza-Diaz J, Mesa M . Vitamin D: Classic and Novel Actions. Ann Nutr Metab. 2018; 72(2):87-95. DOI: 10.1159/000486536. View

16.

Lips P, Eekhoff M, van Schoor N, Oosterwerff M, de Jongh R, Krul-Poel Y . Vitamin D and type 2 diabetes. J Steroid Biochem Mol Biol. 2016; 173:280-285. DOI: 10.1016/j.jsbmb.2016.11.021. View

17.

Fuchs D, Dupon P, Schaap L, Draijer R . The association between diabetes and dermal microvascular dysfunction non-invasively assessed by laser Doppler with local thermal hyperemia: a systematic review with meta-analysis. Cardiovasc Diabetol. 2017; 16(1):11. PMC: 5244618. DOI: 10.1186/s12933-016-0487-1. View

18.

Celikbilek A, Gocmen A, Tanik N, Borekci E, Adam M, Celikbilek M . Decreased serum vitamin D levels are associated with diabetic peripheral neuropathy in a rural area of Turkey. Acta Neurol Belg. 2014; 115(1):47-52. DOI: 10.1007/s13760-014-0304-0. View

19.

Pop-Busui R, Ang L, Holmes C, Gallagher K, Feldman E . Inflammation as a Therapeutic Target for Diabetic Neuropathies. Curr Diab Rep. 2016; 16(3):29. PMC: 5127166. DOI: 10.1007/s11892-016-0727-5. View

20.

Basit A, Abdul Basit K, Fawwad A, Shaheen F, Fatima N, Petropoulos I . Vitamin D for the treatment of painful diabetic neuropathy. BMJ Open Diabetes Res Care. 2016; 4(1):e000148. PMC: 4800070. DOI: 10.1136/bmjdrc-2015-000148. View